Wambolt & Associates’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$746K Hold
2,231
0.25% 96
2025
Q1
$738K Sell
2,231
-4
-0.2% -$1.21K 0.25% 97
2024
Q4
$617K Buy
2,235
+4
+0.2% +$1.27K 0.2% 106
2024
Q3
$777K Sell
2,231
-182
-8% -$62.7K 0.21% 99
2024
Q2
$787K Buy
2,413
+28
+1% +$9.65K 0.23% 100
2024
Q1
$868K Sell
2,385
-151
-6% -$49.7K 0.26% 102
2023
Q4
$759K Hold
2,536
0.25% 124
2023
Q3
$729K Hold
2,536
0.26% 130
2023
Q2
$712K Buy
2,536
+36
+1% +$9.38K 0.25% 130
2023
Q1
$655K Hold
2,500
0.23% 137
2022
Q4
$828K Sell
2,500
-4
-0.2% -$1.27K 0.32% 111
2022
Q3
$695K Hold
2,504
0.3% 117
2022
Q2
$660K Hold
2,504
0.27% 124
2022
Q1
$617K Sell
2,504
-931
-27% -$218K 0.22% 139
2021
Q4
$789K Buy
3,435
+931
+37% +$198K 0.29% 119
2021
Q3
$507K Hold
2,504
0.2% 144
2021
Q2
$597K Hold
2,504
0.25% 126
2021
Q1
$606K Sell
2,504
-500
-17% -$111K 0.32% 107
2020
Q4
$625K Buy
+3,004
New +$589K 0.37% 93

Other funds holding CI

Wambolt & Associates's CI Position: Q2 2025 in Review

Wambolt & Associates held its Cigna (CI) position steady in Q2 2025 at 2,231 shares worth $746K. The position accounts for 0.25% of the portfolio, ranked #96.

Wambolt & Associates first reported a position in CI in Q4 2020 and has held it in 19 quarters since. The position peaked at $868K in Q1 2024. 1,734 funds tracked by Wall St. Rank hold CI as of Q2 2025.

  • Wambolt & Associates held 2,231 shares of Cigna worth $746K as of Q2 2025.
  • Wambolt & Associates left its Cigna share count unchanged in Q2 2025.
  • Cigna made up 0.25% of Wambolt & Associates's portfolio in Q2 2025, its #96 holding.
  • Wambolt & Associates first reported a position in Cigna in Q4 2020 and has held it in 19 quarters since.
  • Wambolt & Associates's Cigna position peaked at $868K in Q1 2024.
  • 1,734 funds tracked by Wall St. Rank held Cigna as of Q2 2025.

Based on Wambolt & Associates's 13F filing for Q2 2025, filed 13 Aug 2025.